ARMATA PHARMACEUTICALS, INC. Earnings Per Share (Diluted)
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Earnings Per Share (Diluted) of -$0.27 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.27.
- ARMATA PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$3.16.
- ARMATA PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.74.
- ARMATA PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.45.
- ARMATA PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2025 was -$4.80.
- ARMATA PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2024 was -$0.89.
- ARMATA PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2023 was -$1.91.
- ARMATA PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2022 was -$1.08.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.27 10-Q · filed 2026-08-12 | -$1.12 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | -$3.16 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | -$4.80 10-K · filed 2026-03-25 | |||||||
| 2025-09-30 | -$0.74 10-Q · filed 2025-11-12 | -$1.37 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | -$0.45 10-Q · filed 2026-08-12 | -$0.63 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | -$0.20 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | -$0.89 10-K · filed 2026-03-25 | |||||||
| 2024-09-30 | -$0.15 10-Q · filed 2025-11-12 | -$0.60 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | -$0.25 10-Q · filed 2025-08-12 | -$0.45 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | -$0.69 10-Q · filed 2025-05-14 | |||||||
| 2023-12-31 | -$1.91 10-K · filed 2025-03-21 | |||||||
| 2023-09-30 | -$0.86 10-Q · filed 2024-11-13 | -$1.36 10-Q · filed 2024-11-13 | ||||||
| 2023-06-30 | -$0.17 10-Q · filed 2024-08-13 | -$0.50 10-Q · filed 2024-08-13 | ||||||
| 2023-03-31 | -$0.40 10-Q · filed 2024-05-07 | |||||||
| 2022-12-31 | -$1.08 10-K · filed 2024-03-21 | |||||||
| 2022-09-30 | -$0.24 10-Q · filed 2023-11-14 | -$0.79 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$0.26 10-Q · filed 2023-08-14 | -$0.55 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$0.30 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | -$0.96 10-K · filed 2023-03-16 | |||||||
| 2021-09-30 | -$0.22 10-Q · filed 2022-11-09 | -$0.73 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | -$0.25 10-Q · filed 2022-08-11 | -$0.52 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | -$0.27 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | -$1.35 10-K · filed 2022-03-17 | |||||||
| 2020-09-30 | -$0.31 10-Q · filed 2020-11-12 | -$0.99 10-Q · filed 2020-11-12 | ||||||
| 2020-06-30 | -$0.26 10-Q · filed 2020-08-13 | -$0.68 10-Q · filed 2020-08-13 | ||||||
| 2019-12-31 | -$2.55 10-K · filed 2021-03-18 | |||||||
| 2019-09-30 | -$0.73 10-Q · filed 2020-11-12 | -$2.11 10-Q · filed 2020-11-12 | ||||||
| 2019-06-30 | -$0.69 10-Q · filed 2020-08-13 | -$1.38 10-Q · filed 2020-08-13 | ||||||
| 2019-03-31 | -$0.11 10-Q · filed 2019-05-06 | |||||||
| 2018-12-31 | -$3.59 10-K · filed 2020-03-19 | -$0.64 10-K · filed 2019-03-25 | ||||||
| 2018-09-30 | -$0.60 10-Q · filed 2019-11-12 | -$0.10 10-Q · filed 2018-11-08 | -$3.35 10-Q · filed 2019-11-12 | -$0.51 10-Q · filed 2018-11-08 | ||||
| 2018-06-30 | -$0.68 10-Q · filed 2019-08-14 | -$0.19 10-Q · filed 2018-08-09 | -$2.76 10-Q · filed 2019-08-14 | -$0.42 10-Q · filed 2018-08-09 | ||||
| 2018-03-31 | -$0.24 10-Q · filed 2019-05-06 | |||||||
| 2017-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2019-03-25 | -$0.33 derived: net income ÷ weighted average shares · filed 2019-03-25 | -$1.39 derived: net income ÷ weighted average shares · filed 2019-03-25 | -$2.18 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | -$0.09 10-Q · filed 2018-11-08 | -$1.23 derived: net income ÷ weighted average shares · filed 2018-11-08 | -$2.18 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | -$1.46 10-Q · filed 2018-08-09 | -$3.09 10-Q · filed 2018-08-09 | ||||||
| 2016-12-31 | -$0.76 10-K · filed 2017-03-27 | -$10.23 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$17.02 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$24.67 10-K · filed 2018-03-14 | ||||
| 2016-09-30 | -$3.23 10-Q · filed 2017-11-14 | -$0.32 10-Q · filed 2016-11-10 | -$9.99 derived: net income ÷ weighted average shares · filed 2017-11-14 | -$17.72 10-Q · filed 2017-11-14 | -$1.77 10-Q · filed 2016-11-10 | |||
| 2016-06-30 | -$7.82 10-Q · filed 2017-08-14 | -$0.78 10-Q · filed 2016-08-15 | -$15.96 10-Q · filed 2017-08-14 | -$1.60 10-Q · filed 2016-08-15 | ||||
| 2016-03-31 | -$0.82 10-K · filed 2017-03-27 | |||||||
| 2015-12-31 | -$0.54 10-K · filed 2017-03-27 | -$0.84 derived: net income ÷ weighted average shares · filed 2016-11-10 | -$1.15 derived: net income ÷ weighted average shares · filed 2016-11-10 | -$1.99 10-K · filed 2016-03-30 | ||||
| 2015-09-30 | -$0.30 10-K · filed 2017-03-27 | -$0.63 derived: net income ÷ weighted average shares · filed 2016-11-10 | -$1.45 10-Q · filed 2016-11-10 | |||||
| 2015-06-30 | -$0.33 10-K · filed 2017-03-27 | $1.17 10-Q · filed 2015-08-13 | -$1.19 10-Q · filed 2016-08-15 | |||||
| 2015-03-31 | -$3.49 10-K · filed 2017-03-27 | |||||||
| 2014-12-31 | -$0.44 10-K · filed 2016-03-30 | -$1.23 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$1.86 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$2.33 10-K · filed 2016-03-30 | $0.07 10-K · filed 2015-04-15 | |||
| 2014-09-30 | -$0.86 10-K · filed 2016-03-30 | $0.06 10-Q · filed 2014-11-14 | -$1.49 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$1.96 10-K · filed 2016-03-30 | $0.07 10-Q · filed 2014-11-14 | |||
| 2014-06-30 | -$0.63 10-K · filed 2016-03-30 | $0.05 10-Q · filed 2014-09-12 | -$1.06 10-K · filed 2016-03-30 | $0.01 10-Q · filed 2014-09-12 | ||||
| 2014-03-31 | -$3.18 10-K · filed 2016-03-30 | |||||||
| 2013-12-31 | -$0.64 10-K · filed 2015-04-15 | |||||||
| 2013-09-30 | -$0.49 10-Q/A · filed 2015-04-15 | -$0.44 10-Q · filed 2014-11-14 | -$0.76 10-Q/A · filed 2015-04-15 | -$0.68 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | -$0.16 10-Q/A · filed 2015-04-15 | -$0.14 10-Q · filed 2014-09-12 | -$0.21 10-Q/A · filed 2015-04-15 | -$0.18 10-Q · filed 2014-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |